The U.S. Food and Drug Administration granted expanded approval to Emergent BioSolutions' smallpox vaccine for use by people at high risk of mpox infection, sending the drugmaker's shares surging 20% ...
Original Image Link
Source:www.reuters.com
Original Image Link
Source:www.reuters.com
Posted: 2024-08-30 03:01:00